» Articles » PMID: 8841336

Validation of the Short Form 36 (SF-36) Health Survey Questionnaire Among Stroke Patients

Overview
Journal Stroke
Date 1996 Oct 1
PMID 8841336
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Few studies have examined the utility of a new generic health status measure, the Short Form 36 health survey questionnaire (SF-36), in stroke patients. Our aim was to test the internal consistency and validity of the SF-36 in a cohort of long-term stroke survivors.

Methods: The Australian version of the SF-36 was tested in 90 consecutive 1-year stroke survivors (mean age, 72 years) identified from our hospital discharge data. The instrument was administered by personal interview. Validity was assessed by comparing patients' scores on the SF-36 with those obtained for the Barthel Index, the 28-item General Health Questionnaire, and the Adelaide Activities Profile, an instrument developed from the Frenchay Activities Index.

Results: The SF-36 was relatively quick and easy to use and had satisfactory internal consistency (Cronbach's alpha > 0.7). For all eight SF-36 health scales, the mean scores for patients dependent in self care and with mental ill health were significantly different from patients without these disabilities, but the strength of the differences varied in a predictable manner. However, the SF-36 social functioning scale did not provide a valid measure of everyday activities relevant to many elderly patients as measured by the Adelaide Activities Profile.

Conclusions: The SF-36 avoids the "ceiling effect" of most disability scales and provides a valid measure of physical and mental health after stroke, but it does not appear to characterize well social functioning. Thus, the instrument may need to be supplemented by other measures for a comprehensive assessment of stroke outcome.

Citing Articles

Spiritual needs and influencing factors among people with stroke in China: a cross-sectional study.

Li Z, Cao X, Li S, Huang T, Liu Y, Qin L BMC Nurs. 2024; 23(1):507.

PMID: 39075439 PMC: 11287944. DOI: 10.1186/s12912-024-02182-7.


Hyperbaric Oxygen Post Established Stroke.

Harrison D, Brasher P, Eng J, Harris D, Hoens A, Khazei A Cureus. 2024; 16(6):e63395.

PMID: 39070389 PMC: 11283856. DOI: 10.7759/cureus.63395.


Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial.

Thijs V, Cloud G, Gilchrist N, Parsons B, Tilvawala F, Ho J Eur Stroke J. 2024; 9(3):789-795.

PMID: 38676623 PMC: 11418453. DOI: 10.1177/23969873241249248.


A multidisciplinary, shared care clinic using personalized medicine and coordinated care in patients with concomitant type 2 diabetes and cardiovascular disease. Protocol and baseline characteristics.

Pontoppidan J, Nielsen E, Olsen M, Skjodt M, Christensen J, Raymond I Prev Med Rep. 2024; 38:102594.

PMID: 38283962 PMC: 10821603. DOI: 10.1016/j.pmedr.2024.102594.


Minimal Clinically Important Difference of Scales Reported in Stroke Trials: A Review.

Mishra B, Sudheer P, Agarwal A, Nilima N, Srivastava M, Vishnu V Brain Sci. 2024; 14(1).

PMID: 38248295 PMC: 10813687. DOI: 10.3390/brainsci14010080.